Skip to main content
. Author manuscript; available in PMC: 2019 Apr 25.
Published in final edited form as: J Mol Genet (Isleworth). 2018 Apr 1;1(1):101. doi: 10.31038/JMG.1000101

Table 1:

FXTAS clinical and molecular findings.

Medical History/Clinical Findings Age at Onset of Symptoms (years)

Generalized Anxiety 10
Bulimia 14
Migraines 16
FXPOI 27
Major Depressive Disorder 30
Dizziness and vertigo 34
Hypotdyroidism 34
Fibromyalgia 34
Chronic Pain 34
Tingling and numbness 39
Memory problems 47
Handwriting problems 47
Balance problem 47
Swallowing problem 47
Tremor 48
Hearing loss 53

Neurological Exam Severity of Symptoms

Right upper extremity Intention tremor (+++)
Postural tremor (++)
Intention tremor(+)
Left upper extremity Postural tremor (+)

Molecular Tests Results

Fragile X DNA test (CGG repeats) 93
FMR1 mRNA level (times normal) 3.71

Diagnosis

FXTAS diagnosis Probable
FXTAS stage 4